NYSE
UHS
Last Price
US $171.21
KEY FIGURES
MKT CAP
$10.4B
EPS
TTM
$25.59
EPS Growth (1Y)
37.34%
PEG
TTM
0.42x
P/E
TTM
6.69x
P/S
TTM
0.56x
YIELD
0.47%
GROWTH (5Y CAGR)
Revenue
Valuation
Financial
Performance
Cash flow to debt coverage
Universal Health Services, Inc. cash flow to debt ratio of 33.85% indicates that the company generates enough cash to cover its debts. This level indicates strong financial health.
Free cash flow growth
Universal Health Services, Inc.'s free cash flow has decreased 24.40% from $1.12B last year to $849.25M, signaling decreasing performance
Debt-to-equity ratio
Universal Health Services, Inc.'s debt to equity ratio is 0.70, which means that the company's assets are unhealthy financed, signaling financial risk.
Debt-to-equity trend
Universal Health Services, Inc.'s debt has decreased relative to shareholder equity from 0.74 last year to 0.70 today, signaling strengthened financials
Net debt to EBITDA
Universal Health Services, Inc. has a net debt to EBITDA ratio of 1.96x, which is below the 3.00x threshold, indicating healthy leverage and financial stability
Interest coverage
Universal Health Services, Inc.'s interest coverage ratio of 13.22 indicates that earnings with good margin can cover interest payments on company debt
Profit margin growth
Universal Health Services, Inc.'s profit margin has increased (16.75%) in the last year from 7.22% to 8.42%, signaling increasing performance
Current ratio
Universal Health Services, Inc.'s short-term assets of $3.41B exceed its short-term liabilities of $3.24B
Return on assets
Universal Health Services, Inc.'s return on assets of 9.58% is higher than the 5.00% threshold, indicating efficient asset utilization
Return on equity
Universal Health Services, Inc.'s return on equity of 20.66%, is higher than 15.00%, indicating good performance
Earnings quality
Universal Health Services, Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Earnings stability
Universal Health Services, Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings
Positive free cash flow
Universal Health Services, Inc. has positive free cash flow, indicating the company generates cash after capital expenditures
Free cash flow yield
Universal Health Services, Inc. has a free cash flow yield of 8.12%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Earnings growth
Universal Health Services, Inc.'s yearly earnings has increased 30.36% since last year from $1.14B to $1.49B, signaling increasing performance
Revenue growth
Universal Health Services, Inc.'s yearly revenue has increased 9.71% since last year from $15.83B to $17.36B, signaling increasing performance
Return on invested capital
ROIC 11.68% (Source: FMP key-metrics). At or above the 10% threshold. Score: 2 of 2. The company is generating returns above the upper end of the typical US weighted-average cost of capital range under this definition of invested capital.
3-year revenue CAGR
Universal Health Services, Inc.'s 3-year revenue CAGR of 9.03% is positive, indicating growing revenue over the past 3 years
Revenue consistency
Universal Health Services, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance
Return on equity consistency
Universal Health Services, Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity
Cash Flow Valuation (DCF)
Universal Health Services, Inc. is overvalued relative to its fair value price of 6.52 based on Discounted Cash Flow model
Earnings yield (TTM)
Universal Health Services, Inc. has an earnings yield of 14.81%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
EBITDA Valuation
Universal Health Services, Inc. is undervalued relative to its fair value price of 217.56 based on EBITDA multiple model
EV/EBITDA (FY)
Universal Health Services, Inc. has an EV/EBITDA ratio of 5.77x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
PEG ratio (TTM/FY)
Universal Health Services, Inc. has a PEG-ratio under 1 which is considered undervalued
Price-to-book ratio (FY)
Universal Health Services, Inc. has a price-to-book ratio of 1.35x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Price-to-sales ratio (TTM)
Universal Health Services, Inc. has a price-to-sales ratio of 0.57x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
20.66%
Return on equity
ROIC: 11.68%
Valuation History
6.9X
Price to Earnings
EV/EBITDA: 5.5X
Cash flow
Profit margin
8.48%
EBITDA
7.98%
Cash flow
-12.18%
Cash Flow (DCF)
Fair Value
Market $171.21
-96.19%
Default assumptions
EBITDA Multiple
Fair Value
Market $171.21
27.07%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.